专利 等待形式审查

COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES

Overview

本页收录老挝专利「COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES」的公开登记要点,由 KOH HWEE LING 于 2017-03-08 提交申请,当前状态为等待形式审查。公开档案中可核验:申请号 P/595,DIP 编号 LAP595,主管局代码 LA,保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-02-27。技术或外观分类记载为 A61K 31/37、A61K 36/75、A61P 33/06。发明人 / 设计人包括 KOH, Hwee Ling、LEE, Ying、TENG, Woon Chien Cecilia。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示:The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutic…。

专利 老挝 DIP

申请号 P/595
申请日期 2017-03-08
申请人 KOH HWEE LING
代理机构 Lao Trademark Agency (LAO IP AGENCY)
类别 A61K 31/37 · A61K 36/75 · A61P 33/06

图样

下载

基础信息

类型
专利
申请号
P/595
状态
等待形式审查
申请人
KOH HWEE LING
代理机构
Lao Trademark Agency (LAO IP AGENCY)
申请日期
2017-03-08
公开/公告日
2026-02-27
国际分类
A61K 31/37 · A61K 36/75 · A61P 33/06
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.

The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。